Korea’s Top Cord Blood Bank, CELLTREE®
CELLTREE® is MEDIPOST’s umbilical cord blood bank that has successfully commercialized the world’s first allogeneic stem cell drug.
Based on world-class stem cell technology, CELLTREE® boasts a unique and thorough management for
extraction, storage, and transplantation of the umbilical cord blood-derived stem cells.
Umbilical cord blood, blood from the umbilical cord of newborn infants, is rich in both the Hematopoietic Stem Cells (HSCs)
which create blood components, and Mesenchymal Stem Cells (MSCs) which grow into tissues such as cartilage, bones and muscle.
This is why umbilical cord blood is widely recognized as a precious life resource which can regenerate many different types of damaged adult tissues and restore their function.
“Value of Cord Blood Storage,
a Once-in-a-Lifetime Opportunity ”
By taking the advantage of the once-in-a-lifetime opportunity only available at birth of the child, parents can have their baby’s umbilical cord blood stored and made available later for Hematopoietic Stem Cell (HSC) transplants if the infant or a family member develops an incurable disease. There is no need to worry about the loss of the limited time-window for treating incurable diseases due to difficulty in locating a stem cell donor with histocompatibility. hUCB-HSCs provide the purest and strongest life force harvested at the moment of birth to enhance the effectiveness of treatment.
“ Even with only 1% chance, we must strive to preserve life.
Let us pursue the value of umbilical cord blood ”
Hematopoietic Stem Cell Transplant
Curable Disease through Clinical Research
The Prestigious Umbilical Cord Blood Bank with Three Key Factors
A cord blood bank of MEDIPOST which
has successfully commercialized the
world’s first allogeneic stem cell drug “The quality of cord blood is determined
by the quality of stem cell technology”
World’s First Allogeneic Stem Cell Drug
The excellence in storage technology
proved by its status of Korea’s largest
HSC transplant program provider
“First step to successful transplantation,
expertise in cord blood storage”
The Korea Marrow Donor Program
(2015, the Ministry of Health and Welfare)
CELLTREE®’s stability and reliability are
recognized by consumers through top market share in UCB-storage
“ CELLTREE® is setting the standard
of cord blood bank industries”
2013. 12, the Ministry of Health and Welfare